Literature DB >> 29934055

Clinical significance of extrathyroidal extension according to primary tumor size in papillary thyroid carcinoma.

Lihua Liu1, Chan Oh1, Jae Hyung Heo2, Hee Sung Park2, Kyungmin Lee2, Jae Won Chang2, Seung-Nam Jung2, Bon Seok Koo3.   

Abstract

BACKGROUND: Extrathyroidal extension (ETE) is a risk factor for poor papillary thyroid carcinoma (PTC) outcomes. However, the clinical significance of ETE according to primary tumor size has not been well-established. The purpose of this study was to compare differences in clinical outcomes, according to the presence and extent of ETE, between different primary tumor size groups.
METHODS: In total, 381 patients with PTC underwent total thyroidectomy with or without lymph node (LN) dissection from 2004 to 2010. We divided the patients into two groups according to primary tumor size: ≤ 1 cm or >1 cm. Each group was further divided into subgroups according to the presence of ETE (ETE vs. no ETE) and degree of ETE (microscopic ETE vs. macroscopic ETE). The clinicopathological features and rate of recurrence during follow-up were compared among groups.
RESULTS: Among the PTC patients with primary tumors >1 cm, patients with ETE had a higher recurrence rate than those without ETE, and only macroscopic ETE affected recurrence in patients with PTC > 1 cm (P < 0.05). However, there was no significant difference in recurrence rates between those without ETE and those with microscopic ETE (P = 0.100). When the primary tumor size was less than 1 cm, there were no difference in recurrence rates between the groups with or without ETE, or between the groups with microscopic and macroscopic ETE (P > 0.05).
CONCLUSIONS: Our data suggests that the presence and degree of ETE may be associated with PTC outcome based on primary tumor size.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Extrathyroidal extension; Papillary thyroid cancer; Primary tumor size; Recurrence

Mesh:

Year:  2018        PMID: 29934055     DOI: 10.1016/j.ejso.2018.05.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.

Authors:  J-W Feng; H Pan; L Wang; J Ye; Y Jiang; Z Qu
Journal:  J Endocrinol Invest       Date:  2019-11-20       Impact factor: 4.256

2.  Lymph node metastasis in the space between the right carotid artery and jugular vein in papillary thyroid carcinoma.

Authors:  Jian Chen; Deguang Zhang; Liang Fang; Gaofei He; Li Gao
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

3.  Clinical Significance of Tumor Size in Gross Extrathyroidal Extension to Strap Muscles (T3b) in Papillary Thyroid Carcinoma: Comparison with T2.

Authors:  Joonseon Park; Il Ku Kang; Ja Seong Bae; Jeong Soo Kim; Kwangsoon Kim
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

4.  Risk Factors and Prediction Model for Lateral Lymph Node Metastasis of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Weili Liang; Lei Sheng; Liguang Zhou; Changyuan Ding; Zhongyang Yao; Chao Gao; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

5.  Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe.

Authors:  Songtao Zhang; Runfang Zhang; Chao Wang; Wenbo Gong; Chen Zheng; Qigen Fang; Liyuan Dai
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.